Media Contacts:
Paul Maccabee/Andy Pollen, Maccabee PR, 612-337-0087
ImpediMed Announces U.S. Commercial Launch of L-Dex® System for Assessment of Lymphedema
in Cancer Survivors
CARLSBAD, CA, January 7, 2016 – ImpediMed Limited(ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid...
